Organon & Co. (LON:0A9W)

London · Delayed Price · Currency is GBP · Price in USD

7.67

-0.29 (-3.66%)

At close: Feb 11, 2026

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Women's Health Revenue	1.75B	1.78B
Women's Health Revenue Growth	-1.41%	4.41%
Biosimilars Revenue	691.00M	662.00M
Biosimilars Revenue Growth	4.38%	11.64%
Established Brands Revenue	3.69B	3.85B
Established Brands Revenue Growth	-4.11%	0.05%
Other Product Group Revenue	82.00M	115.00M
Other Product Group Revenue Growth	-28.70%	-4.96%
Revenue (Total)	6.22B	6.40B
Revenue (Total) Growth	-2.92%	2.23%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States Revenue	1.60B	1.57B
United States Revenue Growth	2.04%	6.36%
Europe and Canada Revenue	1.62B	1.76B
Europe and Canada Revenue Growth	-8.22%	5.38%
Asia Pacific and Japan Revenue	1.00B	1.05B
Asia Pacific and Japan Revenue Growth	-4.76%	-7.00%
China Revenue	829.00M	847.00M
China Revenue Growth	-2.13%	-1.97%
Latin America, Middle East, Russia and Africa Revenue	1.07B	1.03B
Latin America, Middle East, Russia and Africa Revenue Growth	3.67%	7.15%
Other International Revenue	93.00M	137.00M
Other International Revenue Growth	-32.12%	-11.04%
International Revenue	4.61B	4.83B
International Revenue Growth	-4.53%	0.96%
Revenue (Total)	6.22B	6.40B
Revenue (Total) Growth	-2.92%	2.23%

Updated Dec 31, 2025. Data Source: Fiscal.ai.